Gene · 6906
Papers3,003
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,003
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Health-Related Quality of Life in Adrenocortical Carcinoma. | Cancers (Basel) | 2019 | 31597261 | PubTator, text mining | PubMed |
| Apparent resistance to thyroid hormones: From biological interference to genetics. | Ann Endocrinol (Paris) | 2019 | 31590893 | PubTator, text mining | PubMed |
| Optimal Assessment and Quantification of Iodine Nutrition in Pregnancy and Lactation: Laboratory and Clinical Methods, Controversies and Future Directions. | Nutrients | 2019 | 31590373 | PubTator, text mining | PubMed |
| A Chinese Family with Familial Dysalbuminemic Hyperthyroxinemia (FDH) due to R242H Mutation on Human Albumin Gene: Reevaluating the Role of FDH in Patients with Asymptomatic Hyperthyroxinemia. | Int J Endocrinol | 2019 | 31582975 | PubTator, text mining | PubMed |
| Are persistent organic pollutants important in the etiology of feline hyperthyroidism? A review. | Acta Vet Scand | 2019 | 31581952 | PubTator, text mining | PubMed |
| Production of adeno-associated virus vectors for in vitro and in vivo applications. | Sci Rep | 2019 | 31537820 | PubTator, text mining | PubMed |
| Serine protease inhibitors and human wellbeing interplay: new insights for old friends. | PeerJ | 2019 | 31531264 | PubTator, text mining | PubMed |
| Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options. | Drugs Context | 2019 | 31516533 | PubTator, text mining | PubMed |
| Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches. | Environ Health Perspect | 2019 | 31487205 | PubTator, text mining | PubMed |
| Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient's Lifetime. | Adv Ther | 2019 | 31485977 | PubTator, text mining | PubMed |
| Disruption of thyroid hormone regulated proteins and gene expression by polychlorinated biphenyls, polybrominated diphenyl ethers and new flame retardants in residents of an e-waste region. | Environ Pollut | 2019 | 31454572 | PubTator, text mining | PubMed |
| Thyroid hormone levels associate with exposure to polychlorinated biphenyls and polybrominated biphenyls in adults exposed as children. | Environ Health | 2019 | 31443693 | PubTator, text mining | PubMed |
| Thyroid Hormone Distributor Proteins During Development in Vertebrates. | Front Endocrinol (Lausanne) | 2019 | 31440205 | PubTator, text mining | PubMed |
| iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia. | Cancer Manag Res | 2019 | 31440093 | PubTator, text mining | PubMed |
| A Rare Case of Partial Peripheral Thyroid Hormone Resistance Due to a Point Mutation in the Membrane Integrin Α(V)Β(3) and Concomitant Hashimoto`s Thyroiditis. | Open Access Maced J Med Sci | 2019 | 31406543 | PubTator, text mining | PubMed |
| Interconnection between circadian clocks and thyroid function. | Nat Rev Endocrinol | 2019 | 31406343 | PubTator, text mining | PubMed |
| Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists. | Thyroid | 2019 | 31389309 | PubTator, text mining | PubMed |
| A rapid and quantitative technique for assessing IgG monomeric purity, calibrated with the NISTmAb reference material. | Anal Bioanal Chem | 2019 | 31375854 | PubTator, text mining | PubMed |
| 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. | Lancet Oncol | 2019 | 31375469 | PubTator, text mining | PubMed |
| Interpretation of common endocrine laboratory tests: technical pitfalls, their mechanisms and practical considerations. | Clin Diabetes Endocrinol | 2019 | 31367466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6906/papers?page=45